A coupler immunogen trenchant against individual strains of contagion has passed its prototypal form of testing, according to Dr. Christine Turley of the University of Texas at Galveston. Turley, who is administrator of clinical trials and clinical investigate at the Sealy Center for Vaccine Development at UTMB and the study’s capital investigator, said that VaxInnate’s M2e coupler immunogen could mayhap protect against seasonal and pandemic contagion strains.